Intranasal budesonide for the treatment of perennial rhinitis in Thai patients
The efficacy and tolerability of a new intranasal glucocorticosteroid, budesonide, was evaluated in 28 Thai adult patients with perennial rhinitis. After one week pre-treatment observation period, the nasal spray was given as two puffs into each nostril twice daily (400 μg/day) for four weeks. The s...
Saved in:
Main Authors: | C. Bunnag, B. Dhorranintra, P. Jareoncharsri |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/15554 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Intranasal inhalation of beclomethasone dipropionate in the treatment of perennial rhinitis in adults
by: C. Bunnag, et al.
Published: (2018) -
A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis
by: C. Bunnag, et al.
Published: (2018) -
A study of the skin reaction to bacterial vaccine in perennial rhinitis
by: C. Bunnag, et al.
Published: (2018) -
Nasal endoscopic findings in patients with perennial allergic rhinitis
by: Perapun Jareoncharsri, et al.
Published: (2018) -
Epidemiology of rhinitis in thais: Characteristics and risk factors
by: Chaweewan Bunnag, et al.
Published: (2018)